The probability of indicating Osteoprotegrin as a biomarker for osteoporosis in patient with thalassemia major

نویسندگان
Darbandi, Bahram ID 1
Baghersalimi, Adel ID 2
Zare, Roghayeh ID 3
Hassanzadeh Rad, Afagh ID 4
Akhavan, Arian ID 5
Moamer, Farzaneh ID 6
Medghalchi, Abdolreza ID 7
Koohmanaee, Shahin ID 8
Aghaeizadeh Zoroufi, Mohammad ID 9
MirMonsef , Seyyedeh Golnaz ID 10
Golshekan, Kioomars ID 11
Dlili, Setila ID 12

1 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran

2 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran

3 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

4 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran

5 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

6 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

7 Eye Research Center, Guilan University of Medical Sciences, Rasht, Iran

8 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran

9 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

10 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

11 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran

12 Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran

doi
10.18502/ijpho.v11i1.5002
چکیده

Background: Osteoporosis is one of the main causes of morbidity in patients with thalassemia major. Osteoprotegerin (OPG) is secreted by osteoblasts and osteogenic stromal stem cells and protects the skeleton from excessive bone reabsorption. In this study, the authors aimed to assess the relationship between OPG with osteoporosis and osteopenia ...

کلیدواژه‌ها
Beta-Thalassemia, Child, Osteoprotegerin